Login to Your Account



Biogen's Tecfidera Approved as Expected; Launch in 'Days'

By Jennifer Boggs
Managing Editor

Wednesday, March 27, 2013

Just days after winning a thumbs-up from the European Committee for Medicinal Products for Human Use, Biogen Idec Inc.'s much-lauded Tecfidera was approved by the FDA, and analysts have said the drug has a good shot against the two oral multiple sclerosis therapies already on the market.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription